Literature DB >> 23376905

Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder.

G Vijaya1, R Cartwright, A Derpapas, P Gallo, R Fernando, V Khullar.   

Abstract

INTRODUCTION AND HYPOTHESIS: Overactive bladder (OAB) has a multifactorial aetiology, and for some women symptoms may be associated with chronic urothelial inflammation secondary to bacterial colonisation. One marker of such inflammation may be urinary nerve growth factor (NGF). We hypothesised that for women with OAB and urothelial inflammation, urinary NGF would be reduced following antibiotic therapy.
METHODS: Women with overactive bladder and urodynamic diagnosis of detrusor overactivity who were refractory to anticholinergics, and had histological evidence of urothelial inflammation were treated with a 6-week course of rotating antibiotics. Urinary NGF was measured by ELISA before and after treatment. Three-day bladder diaries, the Patients' Perception of Intensity of Urgency Scale, the King's Health Questionnaire and the Patients' Perception of Bladder Condition questionnaire were used to assess subjective and objective outcomes of therapy.
RESULTS: Thirty-nine women with refractory DO were recruited. The NGF levels decreased significantly after antibiotic therapy (Wilcoxon signed rank test; p = 0.015). There were significant improvements in daytime frequency, nocturia and urgency (p < 0.05), and 74 % of women reported improvement in perception of their bladder condition.
CONCLUSIONS: Urinary NGF is responsive to antibiotic therapy. Women with refractory overactive bladder and elevated NGF may benefit from antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23376905     DOI: 10.1007/s00192-012-2038-y

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  30 in total

1.  The prevalence of detrusor overactivity amongst patients with symptoms of overactive bladder: a retrospective cohort study.

Authors:  P Diamond; S Hassonah; M Alarab; D Lovatsis; H P Drutz
Journal:  Int Urogynecol J       Date:  2012-04-25       Impact factor: 2.894

2.  How do urinary diaries of women with an overactive bladder differ from those of asymptomatic controls?

Authors:  Mary P Fitzgerald; Deborah Ayuste; Linda Brubaker
Journal:  BJU Int       Date:  2005-08       Impact factor: 5.588

3.  Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy.

Authors:  Hsin-Tzu Liu; Heng Lin; Hann-Chorng Kuo
Journal:  Neurourol Urodyn       Date:  2011-08-08       Impact factor: 2.696

Review 4.  Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders.

Authors:  Hsin-Tzu Liu; Chia-Yen Chen; Hann-Chorng Kuo
Journal:  J Formos Med Assoc       Date:  2010-12       Impact factor: 3.282

5.  Histological and neurotrophic changes triggered by varying models of bladder inflammation.

Authors:  M C Dupont; J M Spitsbergen; K B Kim; J B Tuttle; W D Steers
Journal:  J Urol       Date:  2001-09       Impact factor: 7.450

6.  Changes in urinary nerve growth factor and prostaglandin E2 in women with overactive bladder after anticholinergics.

Authors:  Kang Jun Cho; Hyo Sin Kim; Jun Sung Koh; Joon Chul Kim
Journal:  Int Urogynecol J       Date:  2012-06-21       Impact factor: 2.894

7.  Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder.

Authors:  Joon Chul Kim; Eun Young Park; Seong Il Seo; Yong Hyun Park; Tae-Kon Hwang
Journal:  J Urol       Date:  2006-05       Impact factor: 7.450

8.  Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.

Authors:  Apostolos Apostolidis; Thomas S Jacques; Alex Freeman; Vinay Kalsi; Roshni Popat; Gwendoline Gonzales; Soumendra N Datta; Shabnam Ghazi-Noori; Sohier Elneil; Prokar Dasgupta; Clare J Fowler
Journal:  Eur Urol       Date:  2008-03-07       Impact factor: 20.096

Review 9.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Authors:  Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer
Journal:  Int Urogynecol J       Date:  2009-11-25       Impact factor: 2.894

Review 10.  Chronic pelvic pain syndrome and the overactive bladder: the inflammatory link.

Authors:  Rajiv Saini; Ricardo R Gonzalez; Alexis E Te
Journal:  Curr Urol Rep       Date:  2008-07       Impact factor: 3.092

View more
  8 in total

1.  Urinary nerve growth factor and a variable solifenacin dosage in patients with an overactive bladder.

Authors:  Seyfettin Ciftci; Cuneyd Ozkurkcugil; Hasan Yilmaz; Murat Ustuner; Ufuk Yavuz; Mustafa Yuksekkaya; Mustafa Baki Cekmen
Journal:  Int Urogynecol J       Date:  2015-08-27       Impact factor: 2.894

2.  Efficacy of Transcutaneous Electrical Nerve Stimulation in the Treatment of Overactive Bladder.

Authors:  Nidhi Sharma; Kaja Rekha; Krishnamurthy Jayashree Srinivasan
Journal:  J Clin Diagn Res       Date:  2016-10-01

Review 3.  Refractory overactive bladder: a common problem?

Authors:  Ulrich Schwantes; Joachim Grosse; Andreas Wiedemann
Journal:  Int Urogynecol J       Date:  2015-03-20       Impact factor: 2.894

4.  Urinary nerve growth factor in patients with detrusor overactivity.

Authors:  A Korzeniecka-Kozerska; A Wasilewska
Journal:  Ir J Med Sci       Date:  2014-06-21       Impact factor: 1.568

Review 5.  Urinary Tract Infection in Overactive Bladder: An Update on Pathophysiological Mechanisms.

Authors:  Kylie J Mansfield; Zhuoran Chen; Kate H Moore; Luke Grundy
Journal:  Front Physiol       Date:  2022-07-04       Impact factor: 4.755

Review 6.  The Potential Role of Urinary Microbiome in Benign Prostate Hyperplasia/Lower Urinary Tract Symptoms.

Authors:  Seong Hyeon Yu; Seung Il Jung
Journal:  Diagnostics (Basel)       Date:  2022-08-01

Review 7.  The use of urinary biomarkers in the diagnosis of overactive bladder in female patients. A systematic review and meta-analysis.

Authors:  Sofia Tsiapakidou; Apostolos Apostolidis; Konstantinos Pantazis; Grigoris F Grimbizis; Themistoklis Mikos
Journal:  Int Urogynecol J       Date:  2021-08-07       Impact factor: 2.894

8.  A blinded observational cohort study of the microbiological ecology associated with pyuria and overactive bladder symptoms.

Authors:  Kiren Gill; Ryoon Kang; Sanchutha Sathiananthamoorthy; Rajvinder Khasriya; James Malone-Lee
Journal:  Int Urogynecol J       Date:  2018-02-17       Impact factor: 2.894

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.